CINCINNATI, Jan. 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that Chairman and Chief Executive Officer Candace Kendle, PharmD will participate in the Wachovia 2008 Healthcare Conference. The conference will be held at the Langham Hotel in Boston, Jan. 29-31, 2008. Kendle's presentation is scheduled for Wednesday, Jan. 30 at 1:30 p.m. Eastern Time.
The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events section) or at http://www.wsw.com/webcast/wa48/kndl. An archived version can be accessed following Kendle's presentation and will be available through Feb. 28. Slides accompanying the presentation will be available by 9 a.m. Eastern Time on Jan. 30 at http://www.kendle.com in the Investor Relations section.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.
|SOURCE Kendle International Inc.|
Copyright©2008 PR Newswire.
All rights reserved